| 1 |
35093063 | Amisulpride withdrawal akathisia responding to aripiprazole with propranolol in first-onset psychosis: a case report. | 2022 Jan 29 |
1 |
| 2 |
35470768 | Pharmacological strategies for sexual recovery in men undergoing antipsychotic treatment. | 2022 May 1 |
1 |
| 3 |
32715655 | Weight gain and metabolic screening in young people with early psychosis on long acting injectable antipsychotic medication (aripiprazole vs paliperidone). | 2021 Aug |
1 |
| 4 |
33235024 | Relationship of Prolactin Concentrations to Steady-State Plasma Concentrations of Aripiprazole in Patients With Schizophrenia. | 2021 Aug 1 |
4 |
| 5 |
33278020 | Metabolic Effects of Aripiprazole and Olanzapine Multiple-Dose Treatment in a Randomised Crossover Clinical Trial in Healthy Volunteers: Association with Pharmacogenetics. | 2021 Feb |
1 |
| 6 |
33347020 | Prolactin and Estrogen Levels in Postmenopausal Women Receiving Aripiprazole Augmentation Treatment for Depression. | 2021 Jan/Feb 01 |
3 |
| 7 |
33496984 | Safety of switching to brexpiprazole in Japanese patients with schizophrenia: A post-hoc analysis of a long-term open-label study. | 2021 Jul |
2 |
| 8 |
33549979 | Factors influencing the effect of aripiprazole on prolactin levels in patients treated with risperidone or paliperidone. Sex seems to matter. | 2021 Feb |
1 |
| 9 |
33880739 | Is Adjunct Aripiprazole Effective in Treating Hyperprolactinemia Induced by Psychotropic Medication? A Narrative Review. | 2021 May |
4 |
| 10 |
34035313 | Efficacy and tolerability of aripiprazole versus D2 antagonists in the early course of schizophrenia: a systematic review and meta-analysis. | 2021 May 25 |
1 |
| 11 |
34189861 | Hypoprolactinemia and hyperprolactinemia in male schizophrenia patients treated with aripiprazole and risperidone and their relationships with testosterone levels. | 2021 Sep |
3 |
| 12 |
34658963 | Efficacy and Safety of Adjunctive Aripiprazole, Metformin, and Paeoniae-Glycyrrhiza Decoction for Antipsychotic-Induced Hyperprolactinemia: A Network Meta-Analysis of Randomized Controlled Trials. | 2021 |
3 |
| 13 |
31520576 | Effects of aripiprazole on circadian prolactin secretion related to pharmacogenetics in healthy volunteers. | 2020 Mar |
6 |
| 14 |
31834097 | Lower Prolactin Levels in Patients Treated With Aripiprazole Regardless of Antipsychotic Monopharmacy or Polypharmacy. | 2020 Jan/Feb |
7 |
| 15 |
32507371 | Pharmacological treatment strategies for lowering prolactin in people with a psychotic disorder and hyperprolactinaemia: A systematic review and meta-analysis. | 2020 Aug |
2 |
| 16 |
32642517 | Data of a meta-analysis on pharmacological treatment strategies for lowering prolactin in people with a psychotic disorder and hyperprolactinaemia. | 2020 Aug |
2 |
| 17 |
33064050 | A safety evaluation of aripiprazole in the treatment of schizophrenia. | 2020 Dec |
1 |
| 18 |
33228575 | Abnormally low prolactin levels in schizophrenia patients after switching to aripiprazole in a randomized trial: a biomarker for rebound in psychotic symptoms? | 2020 Nov 23 |
5 |
| 19 |
30875676 | Aripiprazole for the treatment of duloxetine-induced hyperprolactinemia: A case report. | 2019 May 1 |
1 |
| 20 |
30948205 | [Aripiprazole in the treatment of patients with intellectual disability and elevated prolactin levels]. | 2019 Sep |
1 |
| 21 |
29403128 | Add-on Aripiprazole for Atypical Antipsychotic-induced, Clinically Significant Hyperprolactinemia. | 2018 Jan-Feb |
2 |
| 22 |
29482256 | Effects of Risperidone and Aripiprazole on Serum Levels of Prolactin, Testosterone and Estradiol in Female Patients with Schizophrenia. | 2018 Jul |
3 |
| 23 |
29805808 | Change in Prolactin Levels in Pediatric Patients Given Antipsychotics for Schizophrenia and Schizophrenia Spectrum Disorders: A Network Meta-Analysis. | 2018 |
1 |
| 24 |
29912799 | Adjunct Aripiprazole Reduces Prolactin and Prolactin-Related Adverse Effects in Premenopausal Women With Psychosis: Results From the DAAMSEL Clinical Trial. | 2018 Aug |
6 |
| 25 |
30214207 | Aripiprazole combination for reversal of paliperidone-induced increase in prolactin level. | 2018 |
3 |
| 26 |
28127934 | Antipsychotic augmentation vs. monotherapy in schizophrenia: systematic review, meta-analysis and meta-regression analysis. | 2017 Feb |
1 |
| 27 |
28223031 | Effects of aripiprazole, quetiapine and ziprasidone on plasma prolactin levels in individuals with first episode nonaffective psychosis: Analysis of a randomized open-label 1year study. | 2017 Nov |
3 |
| 28 |
28262171 | Partial regimen replacement with aripiprazole reduces serum prolactin in patients with a long history of schizophrenia: A case series. | 2017 Feb |
1 |
| 29 |
29209406 | Serum prolactin levels and sexual dysfunction in patients with schizophrenia treated with antipsychotics: comparison between aripiprazole and other atypical antipsychotics. | 2017 |
3 |
| 30 |
25711510 | Aripiprazole-Induced Hypoprolactinemia in an Adult Male with First-Episode Psychosis. | 2016 Winter |
3 |
| 31 |
27278054 | Head-to-Head Comparison of Aripiprazole and Risperidone in the Treatment of ADHD Symptoms in Children with Autistic Spectrum Disorder and ADHD: A Pilot, Open-Label, Randomized Controlled Study. | 2016 Aug |
1 |
| 32 |
27281387 | Aripiprazole-Associated Hypoprolactinemia in the Clinical Setting. | 2016 Aug |
4 |
| 33 |
27284453 | Successful treatment of a prolactinoma with the antipsychotic drug aripiprazole. | 2016 |
2 |
| 34 |
27335526 | Aripiprazole-induced Hyperprolactinemia in a Young Female with Delusional Disorder. | 2016 May-Jun |
2 |
| 35 |
27438182 | Comparing the Effectiveness and Safety of the Addition of and Switching to Aripiprazole for Resolving Antipsychotic-Induced Hyperprolactinemia: A Multicenter, Open-Label, Prospective Study. | 2016 Nov/Dec |
1 |
| 36 |
25784810 | Adjunctive treatment with aripiprazole for risperidone-induced hyperprolactinemia. | 2015 |
1 |
| 37 |
26338693 | A Randomized Comparison of Aripiprazole and Risperidone for the Acute Treatment of First-Episode Schizophrenia and Related Disorders: 3-Month Outcomes. | 2015 Nov |
1 |
| 38 |
26587235 | Management of a microprolactinoma with aripiprazole in a woman with cabergoline-induced mania. | 2015 |
3 |
| 39 |
27703744 | Adjunctive aripiprazole in risperidone-induced hyperprolactinaemia: double-blind, randomised, placebo-controlled trial. | 2015 Oct |
4 |
| 40 |
24405794 | The effectiveness of aripiprazole in the management of problem behaviour in people with intellectual disabilities, developmental disabilities and/or autistic spectrum disorder--a systematic review. | 2014 Mar |
1 |
| 41 |
24677189 | The effects of novel and newly approved antipsychotics on serum prolactin levels: a comprehensive review. | 2014 May |
3 |
| 42 |
24911440 | Prolactin deficiency by aripiprazole. | 2014 Aug |
1 |
| 43 |
23375624 | Differences in plasma prolactin levels in patients with schizophrenia treated on monotherapy with five second-generation antipsychotics. | 2013 Apr |
1 |
| 44 |
23647135 | Prolactin serum concentrations during aripiprazole treatment in youth. | 2013 May |
8 |
| 45 |
23936389 | Adjunctive aripiprazole versus placebo for antipsychotic-induced hyperprolactinemia: meta-analysis of randomized controlled trials. | 2013 |
3 |
| 46 |
23968123 | Treating symptomatic hyperprolactinemia in women with schizophrenia: presentation of the ongoing DAAMSEL clinical trial (Dopamine partial Agonist, Aripiprazole, for the Management of Symptomatic ELevated prolactin). | 2013 Aug 22 |
1 |
| 47 |
24021518 | A multicenter, randomized, double-blind, placebo-controlled study of aripiprazole in children and adolescents with Tourette's disorder. | 2013 Aug |
1 |
| 48 |
24023549 | Effect of aripiprazole on cognitive function and hyperprolactinemia in patients with schizophrenia treated with risperidone. | 2013 Aug |
2 |
| 49 |
24096218 | A comparative study of sexual dysfunction in schizophrenia patients taking aripiprazole versus risperidone. | 2013 Apr-Jun |
1 |
| 50 |
22333523 | Hypogonadism due to hyperprolactinemia and subsequent first episode of psychosis. | 2012 Feb |
1 |